SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 23 filers reported holding SOLENO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $93 | -5.1% | 2,288 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $98 | +6.5% | 2,288 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $92 | +35.3% | 2,288 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $68 | +580.0% | 2,288 | 0.0% | 0.00% | – |
Q2 2023 | $10 | +100.0% | 2,288 | 0.0% | 0.00% | – |
Q1 2023 | $5 | 0.0% | 2,288 | 0.0% | 0.00% | – |
Q4 2022 | $5 | – | 2,288 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 7,316,851 | $298,527,521 | 27.58% |
Carlyle Group Inc. | 4,071,562 | $166,364,023 | 15.80% |
Nantahala Capital Management | 3,082,107 | $125,749,966 | 7.40% |
Ally Bridge Group (NY) LLC | 286,162 | $11,675,410 | 6.96% |
COMMODORE CAPITAL LP | 1,425,000 | $58,140,000 | 3.97% |
Ghost Tree Capital, LLC | 300,000 | $12,240,000 | 3.83% |
Vestal Point Capital, LP | 1,200,000 | $48,960,000 | 3.65% |
Altium Capital Management LP | 212,909 | $8,686,687 | 3.54% |
Ikarian Capital, LLC | 445,451 | $18,174,401 | 3.17% |
Perceptive Advisors | 3,204,976 | $130,763,021 | 3.15% |